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We describe an outbreak of hepatitis A which evolved 
in  Northern  Ireland  between  October  2008  and  July 
2009, against a background of large concurrent hepati-
tis A outbreaks in various parts of Europe. Thirty-eight 
cases were defined as outbreak cases using a strati-
fied case definition; 36 were males with a median age 
of 29 years and of the 28 males whose sexual orienta-
tion was known, 26 were men who have sex with men 
(MSM).  Detailed  descriptive  epidemiology  data  col-
lected through standardised questionnaires, together 
with sequencing of a 289 bp fragment of the VP1/2PA 
region  of  the  virus,  significantly  aided  the  under-
standing of the spread of the outbreak when non-MSM 
cases occurred. The sequence of the outbreak strain, 
genotype IA, was indistinguishable from that involved 
in  a  large  outbreak  in  the  Czech  Republic.  Although 
seeded  in  a  generally  susceptible  Northern  Ireland 
population, the outbreak remained mostly contained 
in MSM, showing this sub-population to be the most 
vulnerable  despite  ongoing  hepatitis  A  vaccination 
programmes in genito-urinary medicine clinics.
Introduction 
Hepatitis  A  is  an  acute,  usually  self-limiting  disease 
caused by infection with the hepatitis A virus (HAV) [1]. 
Transmission is usually by the faecal-oral route, includ-
ing  person-to-person  spread,  contaminated  water  or 
food products, but has also been associated with out-
breaks in injecting drug users and men who have sex 
with men (MSM) [2-4]. The mean incubation period is 
28  days  (range  15-50  days).  Asymptomatic  and  mild 
disease  is  common  in  children  but  the  majority  of 
adults  who  become  infected  are  symptomatic,  often 
with  acute  jaundice  [5].  With  increasing  hygiene  in 
developed countries, hepatitis A infection has become 
much less common leading to populations with a large 
majority  of  people  who  are  not  immune.  One  conse-
quence of this is that proportionately more suscepti-
ble adults are infected when outbreaks do occur, and 
consequently more severe clinical symptoms are seen 
[6]. Peak infectivity occurs two weeks before onset of 
jaundice and falls rapidly thereafter. The diagnosis is 
made by serological detection of anti-HAV IgM which 
becomes detectable at the onset of symptoms and can 
persist for up to six months. HAV RNA is also a marker 
of acute infection and is present in the patient’s serum 
prior to the appearance of anti-HAV IgM [7]. In regions 
with a low incidence of HAV infection, sequencing of 
HAV RNA can be used to link apparently sporadic cases 
and outbreaks [8].
Monovalent  and  combined  hepatitis  A  vaccines  have 
been available since 1995 and are all highly immuno-
genic.  Nearly  100%  of  adults  will  develop  protective 
levels  of  antibody  within  one  month  after  a  single 
dose of vaccine [9]. In the United Kingdom (UK), pre-
exposure  vaccination  is  recommended  for  selected 
risk  groups,  including  MSM  who  have  multiple  part-
ners, particularly during periods when outbreaks are 
occurring [5,10]. Hepatitis A vaccine alone or combined 
with human normal immunoglobulin can be effectively 
used in preventing infections in contacts of cases, if 
administered within 14 days of the onset of symptoms 
in the index case [5]. Since 2006, MSM attending the 
healthcare services specialised in sexually transmitted 
infections, the genito-urinary medicine (GUM) clinics, 
in Northern Ireland have been offered combined hepa-
titis A and B vaccination, in line with guidance from the 
British  Association  of  Sexual  Health  and  HIV-Clinical 
Effectiveness Group (UK BASHH) [10]. However, vacci-
nation coverage among MSM is not known.
Hepatitis A is a notifiable disease in Northern Ireland 
(population 1,775,000). Patients presenting with clini-
cal  symptoms  which  are  confirmed  by  the  Regional 
Virology Laboratory are reported to the regional sur-
veillance unit of the Public Health Agency. Since 2003, 
there have been between zero and seven sporadic cases 2 www.eurosurveillance.org
reported annually (Figure 1). After a decade of decrease 
of hepatitis A incidence in Europe an outbreak began in 
the autumn of 2007 in Latvian injecting drug users fol-
lowed by spread into the general population and lasted 
until the end of 2008 [11]. In autumn 2008, the Czech 
and Slovak Republics reported large outbreaks initially 
in injecting drug users and Roma communities respec-
tively, followed by community spread within the gen-
eral population [12,13]. Subsequently outbreaks among 
MSM have been reported from Spain (Barcelona) [14] 
and Italy (Rome) [15]. 
In October 2008, two hepatitis A cases were reported 
in  Northern  Ireland,  followed  by  another  four  in 
November after a median time interval of 30 days. All 
cases were in MSM, aged between 25 and 40 years. An 
outbreak control team was convened in December 2008 
to coordinate outbreak investigations and to undertake 
control measures. An urgent letter was issued to alert 
healthcare providers. The aim of the epidemiological 
study was to describe the course of the outbreak and 
identify  any  possible  common  exposures  for  further 
investigation.
Methods 
Epidemiological investigation
Initially,  an  outbreak  case  was  defined  as  any  resi-
dent of Northern Ireland who tested positive for anti-
HAV IgM after 1 October 2008. In January 2009 cases 
began to occur in heterosexual males and females. At 
this time the outbreak control team asked for all posi-
tive samples to be sequenced in order to understand 
the  progress  of  the  outbreak  which  transcended  the 
MSM population. Unfortunately, as sequencing of anti-
HAV IgM-positive samples was not a routine activity at 
the time, a number of samples had insufficient volume 
for sequencing and others had been discarded. After 
sequencing information became available a stratified 
case definition was used to describe the outbreak. A 
possible outbreak case was classified as a resident of 
Northern Ireland who tested positive for anti-HAV IgM 
after 1 October 2008. A possible case was upgraded 
to  a  confirmed  outbreak  case  if  the  case  was  found 
after  sequencing  to  have  the  genotype  IA  outbreak 
strain  (referred  to  hereafter  as  the  outbreak  strain). 
Any case found to be epidemiologically linked to a con-
firmed case was defined as a probable outbreak case. 
A case was considered to be epidemiologically linked 
if they had been sharing the same household or had 
been in intimate contact with a confirmed case in the 
two months before becoming ill. A case was defined as 
sporadic if any non-outbreak strain was identified in an 
anti-HAV IgM-positive resident of Northern Ireland dur-
ing the study period. 
A standardised questionnaire administered by environ-
mental health officers, part A, was used to collect the 
patients’ demographic and clinical characteristics (age, 
sex, sexual orientation, occupation, place of residence, 
nationality,  symptoms,  onset  date,  and  hospitalisa-
tion status), as well as details of selected food expo-
sures (consumption of shellfish, raw salad, take-away 
food or eating outside the home), travel abroad, and 
contact with a symptomatic hepatitis case in the two 
months before onset of illness. Part B of the standard-
ised questionnaire was administered by GUM special-
ists and used to collect details of sexual orientation, 
number of sexual partners, condom use, visiting and/
or having sex in gay venues, and other sexual behav-
iours, in the two months prior to onset of symptoms. 
Diagnoses of new and past co-infections were also col-
lected. The questionnaires were collated at the Public 
Health Agency surveillance unit and data entered into 
an enhanced surveillance database and STATA (Stata 
Statistical Software: Release 10, StataCorp 2007) was 
used to produce descriptive statistics. 
Virological analysis
Serological diagnosis was performed by the regional 
virology laboratory at Royal Victoria Hospital in Belfast 
using the Abbott Architect anti-HAV IgM assay. Where 
residual  sample  volume  was  available  this  was  for-
warded  to  the  virus  reference  department  (VRD)  of 
the  Health  Protection  Agency  for  HAV  RNA  detection 
and  sequencing.  The  HAV  RNA  was  extracted  from 
serum  and  reverse-transcribed  into  cDNA  by  random 
hexamers. Amplification of the VP1/2PA junction was 
performed by nested PCR as described previously [16] 
using primers HAV6, HAV7 in this reference for primary 
amplification, and BR-9 and BR-5 for secondary amplifi-
cation. The PCR products were sequenced, resulting in 
a 289 bp sequence, and genotype assignment was pre-
formed by alignment and comparison with sequences 
of known genotype in MegAlign (DNASTAR) followed by 
confirmation  using  BLAST  (http://www.ncbi.nlm.nih.
gov/blast/).
Results  
Descriptive epidemiology
From 4 October 2008 to 1 July 2009, a total of 43 acute 
hepatitis A cases were reported; of those, 38 were clas-
sified as outbreak cases and five as sporadic cases. 
Figure 1
Laboratory reports of hepatitis A, Northern Ireland, 
1998–2009 (n=241)
HAV: hepatitis A virus; IgM: immunglobulin M.
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Twenty-eight of the 43 cases occurred between week 
50 2008 and week 15 2009 (Figure 2).
Outbreak cases (n=38)
Of the 38 outbreak cases, 24 met the case definition 
for a confirmed outbreak case, 10 cases were defined 
as possible and four were classified as probable. The 
basis for the classification of the three of the four prob-
able cases was that they were MSM who had house-
hold contact with confirmed cases. The fourth probable 
outbreak case was a man whose female sexual partner 
was found to have the outbreak strain. 
Thirty-six cases were male, with a median age of 29 
years  (range:  18–51  years).  Information  on  sexual 
orientation  was  available  for  28  males,  26  of  whom 
were  MSM.  All  ten  possible  cases  were  MSM.  With 
the exception of the index case who was from another 
European country, all other cases were British or Irish 
citizens. Of the 33 cases for whom occupational details 
were available, eight were food-handlers and two were 
healthcare workers. The eight food-handlers worked in 
eight different retail premises none of which were rec-
ognised gay venues. Information on clinical symptoms 
was available for 31 patients, 30 of whom presented 
with  jaundice.  Other  symptoms  were  nausea  (n=21), 
loss of appetite (n=17), abdominal pain (n=16), fatigue 
(n=14), and fever (n=13). Twenty-five cases were admit-
ted to hospital. 
Food history was recorded for 18 cases. No common 
food  product,  take-away  or  other  catering  establish-
ments  was  identified.  None  of  the  eight  premises 
where  the  food-handling  cases  worked  during  their 
incubation period was named by any other case. 
Seven  of  the  31  cases  with  known  travel  history 
reported travel abroad in the two months prior to ill-
ness. Two MSM cases travelled in the four weeks prior 
to onset of symptoms, one to Prague, Czech Republic, 
and one to Dublin, Republic of Ireland. The other five 
cases travelled within the UK, two of them in the two 
weeks before the onset of symptoms.
Twenty  of  the  outbreak  cases,  all  males,  attended  a 
GUM clinic where they completed a standardised ques-
tionnaire  and  were  screened  for  coinfections.  Eight 
cases, all MSM, were diagnosed with coinfections on 
that  occasion:  three  with  syphilis,  one  with  human 
immunodeficiency virus (HIV), one with HIV and gonor-
rhoea, and three with non-specific urethritis.
Data on sexual behaviour in the two months prior to 
onset of illness was only available for 18 of the male 
cases  who  attended  GUM  services.  Twelve  reported 
having sex with another male in the two months before 
illness; the median number of partners was one (range 
1–3). Of the 12 male cases who reported having anal 
sex with another man, only six declared consistent con-
dom use (‘always’). Of the remaining six males report-
ing no sexual contact in the two-month period, three 
had visited gay clubs during that time. 
Information on history of hepatitis A vaccination was 
not available for the cases. 
Sporadic cases (n=5)
From 14 October 2008 to 8 June 2009, five sporadic 
cases  were  reported.  Three  cases  were  male,  aged 
20-49 years, and two female, aged 20-24 years. Two 
were  MSM  whose  dates  of  onset  were  separated  by 
an interval of six months, and who reported travel to 
Budapest, Hungary, and Barcelona, Spain, in the two 
months prior to onset of illness. The third male case 
declared  only  shellfish  consumption  as  a  risk  factor. 
Two female cases reported travel to England and Africa 
during the incubation period. 
Virology
Twenty-nine of the 43 anti-HAV IgM-positive specimens 
were available for HAV RNA detection and sequencing. 
Sequences  of  the  289  bp  VP1/2PA  fragment  derived 
from 23 of these samples were indistinguishable from 
Figure 2
Hepatitis A cases by specimen date and genotype, Northern Ireland, 4 October 2008-1 July 2009 (n=43)
HAV: hepatitis A virus; IgM: immunglobulin M.
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each  other  and  of  genotype  IA;  this  was  designated 
as the outbreak strain. A further sample had a 99.7% 
homology  (one  mutation  in  the  289  bp  fragment)  to 
the outbreak strain. Given the low incidence of HAV in 
Northern Ireland and the common risk of MSM we took 
this to be an indication that this strain was related to 
the outbreak. The outbreak strain was unlike any strain 
previously sequenced at the VRD. Comparison of the 
outbreak strain with other strains isolated from recent 
outbreaks  in  Europe  found  it  to  be  indistinguishable 
over 289 bp from the strain involved in the outbreak 
in the Czech Republic in 2008 (kindly provided by H 
Vennema).
Viruses  isolated  from  two  non-outbreak  MSM  cases 
shared the same sequence; the two isolates belonged 
to genotype IA but had only 96.9% homology to the 
outbreak strain. This strain had been observed at the 
VRD in other sporadic cases but these had all occurred 
in  mainland  England.  Comparison  of  this  sequence 
with  other  European  outbreak  strains  found  it  to  be 
indistinguishable from the strain involved in the MSM 
community in Barcelona, in 2008 and 2009 (kindly pro-
vided by R Pinto). 
The  remaining  three  samples  sequenced  were  geno-
type IB and were all distinguishable from each other. 
The homologies of these strains to the outbreak strain 
were 91.7%, 90.3% and 84.1%. 
Control measures 
Each case was visited at home or interviewed by tele-
phone by the environmental health officers, in order to 
identify any environmental risk factors and exposures 
and to trace close contacts. All cases were referred to 
GUM clinics and their family and sexual contacts were 
referred to the general practitioner or to the GUM clinic 
to receive hepatitis A vaccine and human normal immu-
noglobulin as appropriate. In cases known to be food 
handlers a risk assessment of the food premise was 
conducted  and  preventive  information  was  provided. 
Outreach activities were undertaken in two of the most 
frequented gay venues in Belfast over a period of two 
months: hepatitis vaccines were offered according to 
personal history, and testing was offered for HIV, syph-
ilis, hepatitis and chlamydia infection. Information on 
hepatitis A and safe sex were distributed in gay venues 
with the assistance of ‘Rainbow’ Sexual Health Project 
volunteers  using  fliers  and  posters.  Information  on 
the outbreak and details on hepatitis A clinical pres-
entation and prevention were posted on their web-site 
(http://www.rainbow-project.org).
Discussion 
This  is  the  first  outbreak  of  hepatitis  A  in  Northern 
Ireland following a decade of low incidence. It occurred 
against  a  background  of  large  concurrent  European 
outbreaks all reported to have started in at-risk groups 
followed by spread into the general population (Figure 
3) [2-4,10,12,13]. The index case became ill after hav-
ing travelled to Prague in September 2008, when the 
Czech outbreak was reaching its peak incidence [12]. 
Comparison  of  the  HAV  RNA  sequence  derived  from 
this outbreak with that of the Czech virus appears to 
confirm an association. 
Contrary  to  the  experience  with  other  European  out-
breaks occurring in 2008-2009 in the Czech Republic, 
Latvia  and  Slovakia,  the  outbreak  reported  here 
remained  largely  confined  to  the  MSM  sub-popula-
tion,  despite  the  majority  of  the  general  population 
in Northern Ireland being susceptible to HAV infection 
[17].  The  potential  for  spread  to  the  community  was 
highlighted  by  the  fact  that  cases  occurred  in  food 
handlers and healthcare workers. The eight food han-
dlers  in  particular  had  the  potential  to  disseminate 
the  virus  widely  given  that  they  worked  at  eight  dif-
ferent premises. Prompt public health action through 
contact  tracing  and  post  exposure  prophylaxis,  pub-
licity  within  the  gay  community  and  the  provision  of 
Figure 3
Hepatitis A outbreak in Northern Ireland (n=40), the 
source outbreak in the Czech Republic (n=1,580) and the 
concurrent outbreak in Barcelona (n=122), 2008-2009
Source of data for the cases in the Czech Republic and Barcelona: 
graphs published in [9,12].
Outbreak in the Czech Republic , genotype IA ,
July-December 2008 
Outbreak in Barcelona, genotype IA (distinct sequence),
September 2008-March 2009
Outbreak in Northern Ireland, genotype IA (Czech sequence
n=38, Barcelona sequence n=2), October 2008-July 2009 
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outreach sessions at selected implicated venues have 
contributed  to  the  apparent  control  of  the  outbreak. 
Collaboration  between  public  health,  environmental 
health, GUM specialists and the voluntary sector was 
essential. 
Our study did not allow an in-depth ascertainment of 
transmission pathways, given that less than half of the 
outbreak cases returned the questionnaires on sexual 
risk behaviour. Similarly we were unable to document a 
specific venue associated with this outbreak. Notably, 
three MSM cases reported they had not had sex in the 
two month prior to illness but had visited gay venues. 
This raises the possibility that transmission may have 
occurred through environmental contamination, a find-
ing also noted in other outbreaks [18]. Transmission via 
food does not seem likely as no common food source 
or catering venue (among food handler cases or subse-
quent cases) was identified.
UK national policy recognises that MSM are a vulner-
able  group  for  hepatitis  A  and  recommends  they  are 
offered pre-exposure vaccination at times of ongoing 
outbreaks [5]. Our experience shows this is important 
even in a region of low incidence, given the potential 
for rapid seeding of outbreaks from elsewhere. 
This is further emphasised by the finding of two spo-
radic MSM cases during this outbreak with a common 
sequence indistinguishable from that implicated in the 
large MSM outbreak in Barcelona. That neither of them 
seeded an outbreak suggests either that they did not 
have sex in Northern Ireland while infectious (probable 
explanation for the case in October 2008) or that the 
preventive control measures were already effective and 
the MSM community alerted (probable explanation for 
the case in May 2009). 
Although sequencing of HAV RNA did not significantly 
aid the management of the outbreak, it enabled us to 
define  the  sporadic  cases  and  demonstrate  that  the 
outbreak was not spreading to the general community. 
In this setting of low HAV incidence, HAV sequencing 
was a valuable tool in linking apparently unlinked cases 
to the outbreak. Sequencing results derived from the 
outbreak enabled us to link the outbreak in Northern 
Ireland  to  the  larger  outbreak  in  the  Czech  Republic 
and to show that two sporadic cases, only one of which 
had  been  to  Spain,  shared  the  same  strain  circulat-
ing in the MSM outbreak in Spain. Comparison of the 
sequences  from  these  two  large  outbreaks  was  only 
possible thanks to the sharing of information from the 
laboratories  that  performed  the  sequencing  because 
at  the  time,  there  was  no  specific  database  for  HAV 
sequences in the public domain. 
Conclusion
This outbreak highlights the importance of timely diag-
nosis and reporting of cases to allow for appropriate 
and targeted control measures. The high rate of other 
sexually  transmitted  infections  (STI)  among  MSM 
cases  confirms  the  worth  of  STI  testing  during  such 
an outbreak. Awareness of the value and availability 
of  hepatitis  A  vaccination  among  MSM  in  Northern 
Ireland must be increased. Sequencing the virus and 
collaborating with other countries involved in similar 
epidemics  helped  us  understand  how  this  outbreak 
spread;  sequencing  of  all  HAV  cases  has  continued 
since this time. It has subsequently come to light that 
HAV sequences can be sent to the Food-borne Viruses 
in  Europe  (FBVE)  network  for  comparison  with  their 
database [19]: this network is currently making its HAV 
sequence database publically available.
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